← Back to guidelines
General Surgery3 papers

Lower esophageal muscular ring

Last edited:

Overview

The lower esophageal muscular ring, also known as the lower esophageal sphincter (LES), plays a critical role in preventing gastroesophageal reflux by maintaining a zone of increased pressure that keeps the esophagus closed off from the stomach when not swallowing. Dysfunction of the LES can lead to conditions such as gastroesophageal reflux disease (GERD) and functional heartburn. Understanding the pathophysiology of the LES, particularly the unique biphasic response involving initial relaxation followed by an after-contraction, is essential for developing targeted therapeutic strategies. This response, mediated by non-adrenergic and non-cholinergic nerves with vasoactive intestinal peptide (VIP) potentially involved in inhibitory mechanisms, highlights the complex neural regulation of this region.

Pathophysiology

The LES exhibits a distinctive biphasic response to electrical field stimulation, characterized by an initial phase of relaxation followed by an after-contraction [PMID:3866257]. This biphasic phenomenon is crucial for the coordinated function of the sphincter, facilitating both the passage of food into the stomach and the subsequent closure to prevent reflux. The initial relaxation phase is essential for swallowing, allowing food and liquids to enter the stomach without obstruction. Subsequently, the after-contraction phase helps to re-establish the pressure gradient necessary to maintain the barrier against reflux.

Pharmacological studies on human lower esophageal circular muscle strips have elucidated the neural mechanisms underlying this response [PMID:3866257]. These investigations reveal that the inhibitory phase, responsible for the initial relaxation, is mediated by nerves that do not operate via adrenergic or cholinergic pathways. Instead, vasoactive intestinal peptide (VIP) emerges as a potential key player in this inhibitory process. VIP, known for its role in modulating smooth muscle relaxation, likely contributes to the LES's ability to relax during swallowing while maintaining overall tone to prevent reflux. This intricate interplay of neural mediators underscores the complexity of LES function and suggests that targeting these pathways could offer therapeutic benefits in managing LES-related disorders.

In clinical practice, understanding these mechanisms helps in diagnosing conditions where LES function is impaired. For instance, persistent relaxation of the LES without adequate after-contraction can lead to chronic GERD, characterized by frequent acid reflux and potential esophageal damage. Conversely, excessive after-contractions might contribute to functional disorders like achalasia, where the LES fails to relax sufficiently, impeding normal passage of food.

Diagnosis

Diagnosing LES dysfunction typically involves a combination of clinical evaluation and diagnostic tests. Common clinical presentations include heartburn, regurgitation, dysphagia, and in severe cases, chest pain. To confirm LES abnormalities, several tools are employed:

  • Endoscopy: Direct visualization of the esophageal mucosa can reveal signs of esophagitis or other structural abnormalities that may correlate with LES dysfunction.
  • Manometry: Esophageal manometry is considered the gold standard for assessing LES function. It measures pressure changes and patterns of contraction, identifying abnormalities such as low LES pressure, prolonged relaxation, or inappropriate contractions.
  • pH Monitoring: Ambulatory pH monitoring helps quantify the frequency and duration of acid reflux episodes, providing indirect evidence of LES incompetence.
  • While these diagnostic methods are robust, the specific identification of LES dysfunction often requires integrating clinical symptoms with objective measurements. Limited evidence suggests that further refinement in diagnostic criteria could enhance early detection and tailored management strategies, though more comprehensive studies are needed to solidify these approaches.

    Management

    The management of LES dysfunction aims to alleviate symptoms and prevent complications, often tailored to the underlying pathophysiology identified through diagnostic assessments. Given the biphasic response observed in LES muscle strips, pharmacological interventions targeting specific mediators have shown promise [PMID:3866257].

    Pharmacological Interventions

  • Blocking After-Contractions: Various agents have demonstrated the ability to independently block the after-contraction phase in LES muscle strips, suggesting potential therapeutic targets [PMID:3866257]. Agents that modulate non-adrenergic and non-cholinergic pathways, possibly including those affecting VIP, could be explored for clinical use. These interventions might help normalize LES function by promoting appropriate relaxation and contraction patterns, thereby reducing symptoms of GERD and functional disorders.
  • Proton Pump Inhibitors (PPIs): For patients with GERD, PPIs remain a cornerstone of treatment, reducing gastric acid secretion and alleviating symptoms associated with acid reflux. While not directly targeting LES function, they can significantly improve quality of life by decreasing esophageal irritation.
  • Prokinetic Agents: In cases where LES relaxation is impaired, such as in achalasia, prokinetic agents like metoclopramide can enhance LES relaxation and improve esophageal peristalsis, facilitating easier passage of food.
  • Lifestyle Modifications

    Lifestyle modifications are essential adjuncts to pharmacological treatments:

  • Dietary Adjustments: Avoiding trigger foods such as spicy, fatty, or acidic foods can reduce symptoms of GERD.
  • Weight Management: Maintaining a healthy weight reduces intra-abdominal pressure, potentially alleviating LES dysfunction.
  • Positioning: Elevating the head of the bed and avoiding lying down immediately after meals can minimize nocturnal reflux episodes.
  • Surgical Interventions

    For refractory cases or severe LES dysfunction, surgical options may be considered:

  • Fundoplication: This procedure reinforces the LES by wrapping the stomach around the lower esophagus, enhancing barrier function against reflux.
  • Endoscopic Procedures: Techniques such as endoscopic suturing or radiofrequency ablation can tighten the LES and improve its function without the need for open surgery.
  • In clinical practice, a multidisciplinary approach combining pharmacological, lifestyle, and surgical interventions, guided by precise diagnostic evaluations, offers the best outcomes for managing LES dysfunction. Tailoring treatment based on individual patient profiles and specific LES abnormalities remains crucial for effective management.

    Key Recommendations

  • Comprehensive Diagnostic Workup: Utilize endoscopy, manometry, and pH monitoring to accurately assess LES function and identify specific dysfunction patterns.
  • Targeted Pharmacotherapy: Consider agents that modulate non-adrenergic and non-cholinergic pathways, particularly those affecting VIP, to normalize LES contraction patterns.
  • Lifestyle Modifications: Encourage dietary changes, weight management, and positional adjustments to complement pharmacological treatments.
  • Multidisciplinary Approach: Integrate medical, surgical, and lifestyle interventions based on the severity and specific nature of LES dysfunction identified through thorough diagnostic evaluation.
  • Regular Follow-Up: Monitor patient response to treatment and adjust management strategies as necessary to optimize outcomes and minimize complications.
  • These recommendations aim to provide a structured approach to managing LES dysfunction, leveraging current understanding of its complex pathophysiology to improve patient care effectively.

    References

    1 McKirdy HC, Marshall RW. Effect of drugs and electrical field stimulation on circular muscle strips from human lower oesophagus. Quarterly journal of experimental physiology (Cambridge, England) 1985. link

    1 papers cited of 3 indexed.

    Original source

    1. [1]
      Effect of drugs and electrical field stimulation on circular muscle strips from human lower oesophagus.McKirdy HC, Marshall RW Quarterly journal of experimental physiology (Cambridge, England) (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG